• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可耐受的血压控制水平对80岁以上患者的死亡率没有影响:来自2009 - 2018年美国国家健康与营养检查调查(NHANES)的见解。

Tolerable blood pressure control levels do not impact mortality of patients over 80-year-old: Insights from NHANES 2009-2018.

作者信息

Si Yueqiao, Lu Binjun, Ma Lanlan, Zheng Juanjuan, Wang Wei Eric

机构信息

Department of Geriatrics, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, 400010, PR China; Department of General Practice, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, PR China.

Department of Geriatrics, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, 400010, PR China.

出版信息

Arch Gerontol Geriatr. 2025 Jul;134:105828. doi: 10.1016/j.archger.2025.105828. Epub 2025 Mar 20.

DOI:10.1016/j.archger.2025.105828
PMID:40186986
Abstract

OBJECTIVE

This study aimed to investigate the impact of blood pressure levels on all-cause and cardiovascular disease (CVD) mortality in hypertensive patients over 80-year-old using data from the National Health and Nutrition Examination Survey (NHANES) 2009-2018.

METHODS

A total of 8406 hypertensive patients under 80-year-old and 1082 hypertensive patients over 80-year-old were included. Kaplan-Meier curves, Cox proportional hazards regression models, and restricted cubic spline plots were employed.

RESULTS

In patients over 80-year-old, neither systolic blood pressure (SBP) nor diastolic blood pressure (DBP) was significantly associated with all-cause or CVD mortality (P > 0.05). However, in hypertensive patients under 80-year-old, significant differences in mortality were observed across different SBP and DBP subgroups (P < 0.05), with an optimal SBP range of 120-140 mmHg associated with reduced all-cause mortality risk. In patients over 80-year-old, male patients, high urinary albumin-to-creatinine ratio, total cholesterol, red blood cells, and elevated lymphocyte and neutrophil percentages were associated with increased all-cause mortality; SBP interaction with these risk factors slightly reduced the hazard ratio values separately.

CONCLUSION

Based on NHANES data from 2009 to 2018, tolerable SBP and DBP levels appear to have no significant impact on all-cause or CVD mortality in hypertensive patients over 80-year-old".

摘要

目的

本研究旨在利用2009 - 2018年美国国家健康与营养检查调查(NHANES)的数据,调查血压水平对80岁以上高血压患者全因死亡率和心血管疾病(CVD)死亡率的影响。

方法

共纳入8406例80岁以下高血压患者和1082例80岁以上高血压患者。采用Kaplan - Meier曲线、Cox比例风险回归模型和受限立方样条图。

结果

在80岁以上患者中,收缩压(SBP)和舒张压(DBP)均与全因或CVD死亡率无显著相关性(P > 0.05)。然而,在80岁以下高血压患者中,不同SBP和DBP亚组的死亡率存在显著差异(P < 0.05),最佳SBP范围为120 - 140 mmHg与全因死亡风险降低相关。在80岁以上患者中,男性患者、高尿白蛋白肌酐比值、总胆固醇、红细胞以及淋巴细胞和中性粒细胞百分比升高与全因死亡率增加相关;SBP与这些危险因素的相互作用分别略微降低了风险比值。

结论

基于2009年至2018年的NHANES数据,可耐受的SBP和DBP水平似乎对80岁以上高血压患者的全因或CVD死亡率没有显著影响。

相似文献

1
Tolerable blood pressure control levels do not impact mortality of patients over 80-year-old: Insights from NHANES 2009-2018.可耐受的血压控制水平对80岁以上患者的死亡率没有影响:来自2009 - 2018年美国国家健康与营养检查调查(NHANES)的见解。
Arch Gerontol Geriatr. 2025 Jul;134:105828. doi: 10.1016/j.archger.2025.105828. Epub 2025 Mar 20.
2
Association of oxidative balance score with blood pressure, all-cause and cardiovascular disease mortality among hypertensive patients: a prospective study.氧化平衡评分与高血压患者血压、全因死亡率和心血管疾病死亡率的关联:一项前瞻性研究。
J Hypertens. 2025 Mar 1;43(3):492-503. doi: 10.1097/HJH.0000000000003931. Epub 2024 Nov 20.
3
Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections From NHANES (National Health and Nutrition Examination Survey).在美国采用收缩压干预试验(SPRINT)强化血压治疗方案避免的潜在死亡和发生的严重不良事件:来自美国国家健康与营养检查调查(NHANES)的预测
Circulation. 2017 Apr 25;135(17):1617-1628. doi: 10.1161/CIRCULATIONAHA.116.025322. Epub 2017 Feb 13.
4
Impact of lower achieved blood pressure on outcomes in hypertensive patients.降压治疗达标对高血压患者预后的影响。
J Hypertens. 2012 Apr;30(4):802-10; discussion 810. doi: 10.1097/HJH.0b013e3283516499.
5
On-Treatment Blood Pressure and Cardiovascular Outcomes in Older Adults With Isolated Systolic Hypertension.老年单纯收缩期高血压患者治疗期间的血压与心血管结局
Hypertension. 2017 Feb;69(2):220-227. doi: 10.1161/HYPERTENSIONAHA.116.08600. Epub 2017 Jan 3.
6
Association of hypertension treatment and control with all-cause and cardiovascular disease mortality among US adults with hypertension.美国高血压患者的高血压治疗和控制与全因和心血管疾病死亡率的关系。
Am J Hypertens. 2010 Jan;23(1):38-45. doi: 10.1038/ajh.2009.191. Epub 2009 Oct 22.
7
Achieved diastolic blood pressure and pulse pressure at target systolic blood pressure (120-140 mmHg) and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials.在高危患者中实现了目标收缩压(120-140mmHg)下的舒张压和脉压,并取得了心血管结局:ONTARGET 和 TRANSCEND 试验的结果。
Eur Heart J. 2018 Sep 1;39(33):3105-3114. doi: 10.1093/eurheartj/ehy287.
8
Mortality implications of lower DBP with lower achieved systolic pressures in coronary artery disease: long-term mortality results from the INternational VErapamil-trandolapril STudy US cohort.在冠心病中,较低的舒张压与较低的收缩压达标相关的死亡率影响:来自国际缬沙坦-特拉唑嗪研究美国队列的长期死亡率结果。
J Hypertens. 2018 Feb;36(2):419-427. doi: 10.1097/HJH.0000000000001559.
9
The effects of control of systolic and diastolic hypertension on cardiovascular and all-cause mortality in a community-based population cohort.基于社区人群队列的收缩压和舒张压控制对心血管和全因死亡率的影响。
J Hum Hypertens. 2013 Nov;27(11):693-7. doi: 10.1038/jhh.2013.22. Epub 2013 Mar 21.
10
Association of optimal blood pressure with mortality in patients taking antihypertensive medications.服用降压药物的患者最佳血压与死亡率的关系。
J Clin Hypertens (Greenwich). 2020 Nov;22(11):2035-2043. doi: 10.1111/jch.14034. Epub 2020 Sep 20.